Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

BLOOMSBURY GENETIC THERAPIES LIMITED

Company number 13593877

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
17 Aug 2022 AP01 Appointment of Dr. Sara Inmaculada Garcia Gomez as a director on 9 August 2022
17 Aug 2022 TM01 Termination of appointment of Simon Aron Goldman as a director on 9 August 2022
17 Aug 2022 AP01 Appointment of Mr. Adrien Felix Lemoine as a director on 9 August 2022
17 Aug 2022 RP04SH01 Second filing of a statement of capital following an allotment of shares on 6 April 2022
  • GBP 11.23510
16 Aug 2022 SH01 Statement of capital following an allotment of shares on 23 March 2022
  • GBP 11.23509
04 May 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
04 May 2022 MA Memorandum and Articles of Association
29 Apr 2022 PSC02 Notification of Utf General Partner 2 Llp as a person with significant control on 6 April 2022
29 Apr 2022 PSC07 Cessation of Ahad Abdul Rahim as a person with significant control on 6 April 2022
29 Apr 2022 SH01 Statement of capital following an allotment of shares on 6 April 2022
  • GBP 0.01001
  • ANNOTATION Clarification a second filed SH01 was registered on 17/08/22
25 Apr 2022 AD01 Registered office address changed from 97 Tottenham Court Road London W1T 4TP United Kingdom to 30 Broad Street Great Cambourne Cambridge CB23 6HJ on 25 April 2022
12 Apr 2022 TM01 Termination of appointment of Ahad Abdul Rahim as a director on 6 April 2022
12 Apr 2022 AP01 Appointment of Dr. Frank Murdoch Armstrong as a director on 6 April 2022
12 Apr 2022 AP01 Appointment of Dr. Leigh Pauline Brody as a director on 6 April 2022
12 Apr 2022 AP01 Appointment of Dr. Simon Aron Goldman as a director on 6 April 2022
29 Mar 2022 RESOLUTIONS Resolutions
  • RES13 ‐ Sub-division 23/03/2022
29 Mar 2022 SH02 Sub-division of shares on 23 March 2022
17 Nov 2021 AA01 Current accounting period extended from 31 December 2021 to 31 December 2022
14 Sep 2021 RESOLUTIONS Resolutions
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2021-09-01
02 Sep 2021 AA01 Current accounting period shortened from 31 August 2022 to 31 December 2021
31 Aug 2021 NEWINC Incorporation
Statement of capital on 2021-08-31
  • GBP .01